Relapsed/refractory follicular lymphoma Clinical Trials
Conditions / Relapsed/refractory follicular lymphoma
Delta Trials tracks 11 clinical trials for Relapsed/refractory follicular lymphoma in its publicly accessible dataset. Among the listed trials, 6 open for participant enrollment and 2 trials have reached completion. This research is carried out at 502 clinical sites around the world. An additional 3 trials have active registrations outside the recruiting and completed categories. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
11
Total Trials
6
Recruiting
2
Completed
3
Other Active
0
Terminated since 2020
502
Study Locations
Browse by location (502 total)
- Madrid, Spain 5 trialsAll trials in Madrid, Spain
- Salamanca, Spain 5 trialsAll trials in Salamanca, Spain
- Paris, France 5 trialsAll trials in Paris, France
- Paris, France 5 trialsAll trials in Paris, France
- Milan, Italy 5 trialsAll trials in Milan, Italy
- Beijing, China 4 trialsAll trials in Beijing, China
- Barcelona, Spain 4 trialsAll trials in Barcelona, Spain
- London, United Kingdom 4 trialsAll trials in London, United Kingdom
- Seville, Spain 4 trialsAll trials in Seville, Spain
- Houston, United States 4 trialsAll trials in Houston, United States
- Nanjing, China 3 trialsAll trials in Nanjing, China
- Zhengzhou, China 3 trialsAll trials in Zhengzhou, China
- São Paulo, Brazil 3 trialsAll trials in São Paulo, Brazil
- Kraków, Poland 3 trialsAll trials in Kraków, Poland
- Warsaw, Poland 3 trialsAll trials in Warsaw, Poland
- İstanbul, Turkey (türkiye) 3 trialsAll trials in İstanbul, Turkey (türkiye)
- Rio de Janeiro, Brazil 3 trialsAll trials in Rio de Janeiro, Brazil
- Shanghai, China 3 trialsAll trials in Shanghai, China
- Ghent, Belgium 3 trialsAll trials in Ghent, Belgium
- Rouen, France 3 trialsAll trials in Rouen, France